VA
GSK icon

VestGen Advisors’s GSK GSK Stock Holding History

VestGen Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.35M Buy
26,565
+1,286
+5% +$69.7K 0.04% 387
2025
Q4 		$1.24M Sell
25,279
-61,951
-71% -$2.89M 0.05% 316
2025
Q3 		$3.76M Buy
87,230
+2,555
+3% +$99.8K 0.13% 161
2025
Q2 		$3.19M Sell
84,675
-4,170
-5% -$159K 0.13% 162
2025
Q1 		$3.44M Buy
+88,845
New +$3.25M 0.16% 136

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

VestGen Advisors's GSK Position: Q1 2026 in Review

VestGen Advisors increased its GSK (GSK) stake by 5.1% in Q1 2026, buying an estimated $69.7K and bringing the position to 26,565 shares worth $1.35M. The position accounts for 0.04% of the portfolio, ranked #387.

VestGen Advisors first reported a position in GSK in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.76M in Q3 2025. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • VestGen Advisors held 26,565 shares of GSK worth $1.35M as of Q1 2026.
  • VestGen Advisors bought 1,286 GSK shares in Q1 2026, an estimated $69.7K.
  • GSK made up 0.04% of VestGen Advisors's portfolio in Q1 2026, its #387 holding.
  • VestGen Advisors first reported a position in GSK in Q1 2025 and has held it in 5 quarters since.
  • VestGen Advisors's GSK position peaked at $3.76M in Q3 2025.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on VestGen Advisors's 13F filing for Q1 2026, filed 14 May 2026.